Research Site

Bialystok, Podlaskie Voivodeship 15-879

1 studies enrolling now · 9 studies all time

What they study most

Adenocarcinoma, Arthritis, Rheumatoid, Carcinoma, Non-Small-Cell Lung, Lung Diseases, Lung Neoplasms, Multiple Sclerosis, Relapsing Remitting Multiple Sclerosis, Relapsing-Remitting Multiple Sclerosis, Rheumatoid Arthritis, Type 2 Diabetes

Studies at this site

• A Study to Identify and Characterize Patients With Type 2 Diabetes Mellitus for Possible Participation in Ongoing or Future Type 2 Diabetes Mellitus Clinical Studies — Recruiting now
• A Study to Evaluate the Safety and Efficacy of VIB4920 in Participants With Rheumatoid Arthritis — Completed
• Phase I/II Study of CK-101 in NSCLC Patients and Other Advanced Solid Tumors — Completed
• Study to Assess if ABP 798 is Safe & Effective in Treating Moderate to Severe Rheumatoid Arthritis (RA) Compared to Rituximab — Completed
• Long-Term Extension Study in Participants With Multiple Sclerosis Who Have Completed Study 205MS301 (NCT01064401) to Evaluate the Safety and Efficacy of BIIB019 — Stopped early
• Study to Assess if ABP710 is Safe & Effective in Treating Moderate to Severe Rheumatoid Arthritis Compared to Infliximab — Completed
• Long-term Safety and Efficacy of ABP 501 in Subjects With Moderate to Severe Rheumatoid Arthritis — Completed
• Efficacy and Safety of BIIB019 (Daclizumab High Yield Process) Versus Interferon β 1a in Participants With Relapsing-Remitting Multiple Sclerosis — Completed
• Study Evaluating Rebif, Copaxone, and Tysabri for Active Multiple Sclerosis — Stopped early